MOLECISION Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for MOLECISION with the United States Patent and Trademark Office. The USPTO has given the MOLECISION trademark a serial number of 79300142. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The MOLECISION trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic reagents for medical purposes; reagents for medical purposes; biological preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, as well as quantitative or qualitative detection of various analytes in human serum, plasma or other body fluids; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; Chemical preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, as well as quantitative or qualitative detection of various analytes in human serum, plasma or other body fluids; preparations for detecting genetic predispositions for medical purposes; chemical preparations for the diagnosis of pregnancy; reagents for use in medical genetic testing
molecision

General Information


Serial Number79300142
Word MarkMOLECISION
Filing DateTuesday, September 15, 2020
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6430697
Registration DateTuesday, July 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Goods and ServicesDiagnostic reagents for medical purposes; reagents for medical purposes; biological preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, as well as quantitative or qualitative detection of various analytes in human serum, plasma or other body fluids; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; Chemical preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, as well as quantitative or qualitative detection of various analytes in human serum, plasma or other body fluids; preparations for detecting genetic predispositions for medical purposes; chemical preparations for the diagnosis of pregnancy; reagents for use in medical genetic testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Saturday, January 15, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 10, 2021GENERIC MADRID TRANSACTION SENT TO IB
Friday, December 10, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, October 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 21, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 7, 2021REFUSAL PROCESSED BY IB
Wednesday, February 17, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 17, 2021REFUSAL PROCESSED BY MPU
Friday, February 5, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 4, 2021NON-FINAL ACTION WRITTEN
Thursday, January 28, 2021ASSIGNED TO EXAMINER
Tuesday, December 22, 2020APPLICATION FILING RECEIPT MAILED
Friday, December 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB